Stock Quote
Amgen Inc. (AMGN.O) (Nasdaq)
| Name | Current Position | Compensation |
|---|---|---|
| Sharer, Kevin | Chairman of the Board, President, Chief Executive Officer | 14,512,800 |
| Bradway, Robert | Chief Financial Officer, Executive Vice President | 4,236,080 |
| Bonanni, Fabrizio | Executive Vice President - Operations | 6,268,960 |
Profile
Company Address
One Amgen Center Drive
Thousand Oaks CA 91320
P: +1805.4471000
F: +1805.4471010
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.31 | +0.37 |
| Roche Holding Ltd. | CHF162.70 | +1.60 |
| Roche Holding Ltd. | CHF167.30 | +1.80 |
| AMGN.O | Industry | |
|---|---|---|
| P/E(TTM) | 12.33 | 12.80 |
| P/S(TTM) | 3.84 | 29.90 |
| ROI(TTM) | 13.62 | 2.35 |
| ROE(TTM) | 21.71 | 3.59 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 1.20 |
| EPS Est. (Current Year) | 5.05 |
| Total Revenue | $3,812.00M |
| Net Income | $1,386.00M |
| EPS | $1.36 |

